Medicare Enrolled

Dr. Rabih Loutfi, MD

Pulmonary Disease · Sarasota, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1921 WALDEMERE ST STE 705, Sarasota, FL 34239
9413665864
In practice since 2007 (18 years)
NPI: 1447452842 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Loutfi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Loutfi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Loutfi

Dr. Rabih Loutfi is a pulmonary disease in Sarasota, FL, with 18 years in practice. Based on federal Medicare data, Dr. Loutfi performed 3,750 Medicare services across 2,952 unique beneficiaries.

Between the years covered by Open Payments, Dr. Loutfi received a total of $7,936 from 47 pharmaceutical and/or device companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Loutfi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 11% volume in FL$ $7,936 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,750
Medicare services
Top 11% in FL for pulmonary disease
2,952
Unique beneficiaries
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~208 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)886$95$214
Hospital follow-up visit, high complexity569$96$211
Critical care, first 30-74 min511$174$457
Office visit, established patient (20-29 min)256$65$145
Test to measure expiratory airflow and volume changes before and after medication administration173$28$120
Hemoglobin measurement172$5$14
Test to examine how well the lungs exchange gases172$42$107
Initial hospital admission, high complexity161$140$411
Sleep study in sleep lab with continuous airway pressure (6 years or older)156$487$1,287
Sleep study in sleep lab (6 years or older)153$466$1,224
Test for exercise-induced lung stress121$27$112
Test to determine lung volumes using gas dilution or washout90$33$83
New patient office visit (45-59 min)85$130$332
Test to determine lung volumes using sensors69$42$104
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation69$69$285
Office visit, established patient, complex (40-54 min)40$138$290
Critical care, each additional 30 minutes31$88$222
New patient office visit, complex (60-74 min)21$175$417
Test to measure expiratory airflow and volume15$20$71
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,936
Total received (2018-2024)
Avg $1,134/year across 7 years
Top 26% in FL for pulmonary disease
47
Companies
436
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,786 (98.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$150 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,520
2023
$1,268
2022
$734
2021
$1,094
2020
$853
2019
$1,169
2018
$1,298

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$1,478
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,131
AstraZeneca Pharmaceuticals LP
$627
Actelion Pharmaceuticals US, Inc.
$591
Insmed, Inc.
$558
United Therapeutics Corporation
$412
Regeneron Healthcare Solutions, Inc.
$364
Gilead Sciences, Inc.
$248
Bayer HealthCare Pharmaceuticals Inc.
$225
Janssen Pharmaceuticals, Inc
$183
Shionogi Inc
$173
COMSORT, Inc
$150
Merck Sharp & Dohme LLC
$143
Grifols USA, LLC
$143
Inspire Medical Systems, Inc.
$138
Maquet Cardiovascular U.S. Sales, L.L.C.
$123
Shire North American Group Inc
$99
Electromed, Inc.
$98
Genentech USA, Inc.
$82
Takeda Pharmaceuticals U.S.A., Inc.
$75
GENZYME CORPORATION
$75
HARMONY BIOSCIENCES LLC
$72
Harmony Biosciences LLC
$69
Pulmonx Corporation
$68
Philips Electronics North America Corporation
$60
Mylan Specialty L.P.
$42
Bayer Healthcare Pharmaceuticals Inc.
$39
Nabriva Therapeutics, plc
$39
Jazz Pharmaceuticals Inc.
$34
Resmed Corp
$34
Mallinckrodt LLC
$33
Advanced Respiratory, Inc
$30
Inogen, Inc.
$30
JAZZ PHARMACEUTICALS INC.
$29
Circassia Pharmaceuticals Inc
$27
ADVANCED RESPIRATORY, INC
$24
Vapotherm Inc
$22
Mallinckrodt Hospital Products Inc.
$21
Pharming Healthcare, Inc.
$20
Sunovion Pharmaceuticals Inc.
$19
Covis Pharma GmBH
$19
Boston Scientific Corporation
$18
CSL Behring
$16
Tactile Systems Technology Inc
$16
Teva Pharmaceuticals USA, Inc.
$15
Ceribell, Inc.
$12
PORTOLA PHARMACEUTICALS, INC.
$12
Top 3 companies account for 40.8% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACQUIRE · ACTHAR · AIR 11 · AIRSENSE · ANORO · ANORO ELLIPTA · Adempas · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BROVANA · CARDIOHELP · CHARTIS CATHETER · Ceribell Rapid Response EEG · DIFICID · DUPIXENT · Esbriet · FASENRA · Fetroja · Flexitouch Plus · GLASSIA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · KEYTRUDA · Kcentra · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · ORENITRAM · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · REMODULIN · RUCONEST · SMARTVEST · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TERLIVAZ · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · VAPOTHERM · WAKIX · WINREVAIR · Wakix · XARELTO · Xenleta · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $212 per 100 Medicare services performed
Looking for a pulmonary disease in Sarasota?
Compare pulmonary diseases in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
31
Per 100K population
6.9
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Loutfi is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Loutfi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Loutfi performed 886 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Loutfi receive payments from pharmaceutical companies?
Yes. Dr. Loutfi received a total of $7,936 from 47 companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Loutfi's costs compare to other pulmonary diseases in Sarasota?
Dr. Loutfi's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Loutfi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →